As shown in Figure 2 and 3, the pooled SMDs for alogliptin 12.5 mg treated vs controls, and alogliptin 25 mg treated vs controls demonstrated a significant reduction in HbA1c in patients treated ...

Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

A new study finds SGLT2 inhibitors like Jardiance and GLP-1 drugs like Ozempic provide different benefits depending on the ...

Nesina (alogliptin) Glucagon-Like Peptide-1 Agonists (GLP-1s) Glucagon-like peptide-1 agonists (GLP-1s) can increase the release of insulin when blood sugar is rising and help with weight loss by ...

She had no known drug allergies, and her drug history included alogliptin, glimepiride, metformin, olmesartan and simvastatin. She received the first dose of AstraZeneca COVID-19 vaccination 8 days ...

For patients with heart failure, a greater focus on medication management may be needed in order to mitigate exacerbations caused by certain drugs.

Insulin, sulfonylureas, and TZDs are diabetes medications that may cause weight gain. But some, like metformin, may have weight loss potential. Others may be neutral to any weight changes. Weight ...

The rising trend in health and lifestyle related problems in the world warrants us to be well informed and health-conscious of the latest happenings in this field. Medindia offers a freely ...